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Background: Timing of surgical referral in patients with asymptomatic type II mitral regurgitation (MR) is often difficult to determine. The purpose 
of this study is to examine the prognostic value of exercise stress echocardiography (ESE) in these patients.
Methods: 107 patients undergoing ESE for the evaluation of at least moderate MR and who did not undergo surgical intervention were identified 
by chart review. Exercise data as well as echocardiographic parameters pre- and post-exercise were collected. Follow-up for long-term outcomes, 
including development of atrial fibrillation (AF), development of heart failure (HF) and death, was obtained.
Results: Baseline characteristics of this cohort are reported in Table 1. The average exercise time on the Bruce protocol was 10.6 ± 2.8 minutes 
with an average functional capacity of 12.5±3.5 metabolic equivalents (METs). In the univariate analysis, body mass index, METs and biplane 
ejection fraction predicted development of heart failure, and METs and biplane ejection fraction predicted the combined endpoint. In the 
multivariate analysis, METs predicted the development of heart failure and the combined endpoint. Events were significantly decreased in the group 
achieving > 11.7 METs (Table 1).
Conclusions: Functional capacity (METs) is an important predictor of long-term outcomes in asymptomatic patients with significant type II MR, 
and a strategy of “watchful waiting” may be employed in those with better functional capacity. 
<11.7 METs (n=37) >11.7 METs (n=70)
Female Gender - N (%) 20 (54%) 37 (53%)
Age (years) 63.3 ± 13.7 49.0 ± 12.9*
History of coronary artery disease 3 (8%) 4 (6%)
History of hypertension 22 (59%) 16 (23%)*
MR severity
Moderate
Moderate to Severe
Severe
6 (16%)
7 (19%)
24 (65%)
14 (20%)
17 (24%)
39 (56%)
Biplane ejection fraction (%) 0.6 ± 0.1 0.6 ± 0.1
Left atrial volume index (mL/m2) 38.2 ±13.0 33.8 ±12.0*
Change in heart rate with exercise 74 ± 22.0 95.3 ± 18.4*
Changes in systolic blood pressure with exercise 37.8 ± 20.9 41.6 ± 18.0
Change in diastolic blood pressure with exercise -0.4 ± 13.2 -5.7 ± 12.0*
Pre-exercise right ventricular systolic pressure (mmHg) 30.0 ± 9.1 23.9 ± 6.0*
Post-exercise right ventricular systolic pressure (mmHg) 47.2 ± 11.6 36.1 ± 9.4*
Outcomes (average follow-up 3.2±1.9 years):
Development of AF 6 (16%) 9 (9%)
Development of HF 5 (14%) 3 (4%)
Death 1 (3%) 0 (0.0%)
Combined endpoint (AF, HF, death) 10 (27%) 8 (11%)*
*p<0.05 versus <11.7 METs
